LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
9.67
+0.32 (3.42%)
Apr 2, 2026, 4:00 PM EDT - Market closed
LENZ Therapeutics Market Cap
LENZ Therapeutics has a market cap or net worth of $303.2 million as of April 2, 2026. Its market cap has decreased by -56.86% in one year.
Market Cap
303.20M
Enterprise Value
11.66M
1-Year Change
-56.86%
Ranking
Category
Stock Price
$9.67
Market Cap Chart
Since the IPO on March 22, 2024, LENZ Therapeutics's market cap has decreased from $413.64M to $303.20M, a decrease of -26.70%. That is a compound annual growth rate of -14.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 303.20M | -39.44% |
| Dec 31, 2025 | 500.64M | -36.94% |
| Dec 31, 2024 | 793.95M | 91.94% |
| Mar 22, 2024 | 413.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Opus Genetics | 323.73M |
| Neurogene | 322.23M |
| Surrozen | 320.13M |
| Greenwich LifeSciences | 316.16M |
| Palisade Bio | 313.52M |
| Climb Bio | 313.36M |
| Inhibikase Therapeutics | 306.76M |
| Adlai Nortye | 301.84M |